Reborn Coffee Closes Master License Agreement for UAE
June 27, 2024 08:31 ET
|
REBORN COFFEE, INC.
Reborn Coffee Closes Master License Agreement for UAE
Oragenics Develops Automated Intranasal Device for Treating Concussed Patients
June 27, 2024 08:30 ET
|
Oragenics
SARASOTA, Fla., June 27, 2024 (GLOBE NEWSWIRE) -- Oragenics, Inc. (NYSE American: OGEN), a company focused on developing unique, intranasal pharmaceuticals for the treatment of neurological...
Cerro de Pasco Resources Completes Payment for Critical Easement, Mobilizes Drilling Program and Prepares Financing
June 27, 2024 08:30 ET
|
Cerro de Pasco Resources
NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES MONTRÉAL, June 27, 2024 (GLOBE NEWSWIRE) -- Cerro de Pasco Resources Inc. (CSE:CDPR) (OTCPK: GPPRF)...
Growing Pipeline and Approvals of Injectables and Increasing Demand for Gene Therapies to Surge Sterile Injectable CDMO Market at a CAGR of 11.7% by 2034 | Future Market Insights, Inc.
June 27, 2024 08:30 ET
|
Future Market Insights Global and Consulting Pvt. Ltd.
NEWARK, Del, June 27, 2024 (GLOBE NEWSWIRE) -- As per Future Market Insights (FMI) latest industry analysis, the global Sterile Injectable CDMO Market was valued at around USD 10.1 billion in 2023...
NewtekOne, Inc. Declares a Quarterly Dividend of $0.19 per Share
June 27, 2024 08:30 ET
|
NewtekOne, Inc.
BOCA RATON, Fla., June 27, 2024 (GLOBE NEWSWIRE) -- NewtekOne, Inc. (the “Company”) (NASDAQ: NEWT), today announced that its Board of Directors declared a quarterly cash dividend of $0.19 per share...
Kane Biotech Makes First Commercial Sale of revyve™ Antimicrobial Wound Gel to ProgenaCare Global
June 27, 2024 08:30 ET
|
Kane Biotech Inc.
WINNIPEG, Manitoba, June 27, 2024 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (“Kane Biotech” or “Kane”) announces that it has made its first commercial-scale sale of...
Femasys to Participate in European Society of Human Reproduction and Embryology 40th Annual Meeting in Amsterdam
June 27, 2024 08:30 ET
|
Femasys Inc.
ATLANTA, June 27, 2024 (GLOBE NEWSWIRE) -- Femasys, Inc., (Nasdaq: FEMY), a leading biomedical company focused on addressing significant unmet needs of women worldwide with a broad portfolio of...
CytoDyn Announces Start of Preclinical MASH Study, Results Expected in Fall 2024
June 27, 2024 08:30 ET
|
CytoDyn Inc.
VANCOUVER, Washington, June 27, 2024 (GLOBE NEWSWIRE) -- CytoDyn Inc. (OTCQB: CYDY) ("CytoDyn" or the "Company"), a biotechnology company developing leronlimab, a CCR5 antagonist with the potential...
ARB IOT Group Limited Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency
June 27, 2024 08:30 ET
|
ARB IOT Group Ltd
Selangor, Malaysia, June 27, 2024 (GLOBE NEWSWIRE) -- ARB IOT Group Limited ("ARB" or the "Company") (NASDAQ: ARBB), a provider of complete solutions to clients for the integration of Internet of...
VERSES Announces Corporate Update Webinar
June 27, 2024 08:30 ET
|
VERSES AI Inc.
VANCOUVER, British Columbia, June 27, 2024 (GLOBE NEWSWIRE) -- VERSES AI Inc. (CBOE:VERS) (OTCQB:VRSSF) (“VERSES” or the “Company”), a cognitive computing company developing next-generation...